Literature DB >> 785003

The relevance of growth rates in urine to the pathogenesis of urinary-tract infections due to Micrococcus subgroup 3 (Staphylococcus saprophyticus biotype 3).

J D Anderson, H L Forshaw, M A Adams, W A Gillespie, M A Sellin.   

Abstract

A novobiocin-resistant "biotype" of Micrococcus subgroup 3 (Staphylococcus saprophyticus) is known to be a primary pathogen of the female urinary tract and to cause infections as severe as those produced by Escherichia coli. The growth characteristics of this virulent biotype were compared in vitro with those of other Micrococcaceae and of E. coli to determine whether rapid growth explains the virulence of the biotype. Nutrient broth was shown to have growth-supporting qualities that differed from those of urine and it was therefore unsuitable for these studies. In urine, the virulent biotype grew more slowly, had a longer lag period, and reached much lower final viable counts than did Escherichia coli. Surprisingly, the virulent biotype also grew more slowly and reached a lower final viable count than did several other Micrococcaceae isolated from the urinary tract of healthy women. Urine from women who had suffered a recent infection with the virulent biotype had growth-supporting properties similar to those of urine from healthy women. Experiments with filtered forestream urine suggested that urethral secretions do not contain a factor determining growth rates of this organism in urine. The possibility that virulent strains adapt to rapid growth in urine was excluded. No evidence was obtained that the virulent biotype inhibits the growth of other Micrococcaceae in urine. Ability to grow rapidly in urine does not therefore explain the virulence of novobiocin-resistant strains of subgroup-3 micrococci.

Entities:  

Mesh:

Year:  1976        PMID: 785003     DOI: 10.1099/00222615-9-3-317

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  6 in total

1.  Phagocytosis and intracellular killing of coagulase-negative staphylococci.

Authors:  F Namavar; J de Graaff; D M MacLaren
Journal:  Med Microbiol Immunol       Date:  1979-03-13       Impact factor: 3.402

2.  Commercial kit for preliminary identification of Staphylococcus saprophyticus in urine.

Authors:  K K Christensen; P Christensen
Journal:  Eur J Clin Microbiol       Date:  1986-02       Impact factor: 3.267

3.  Comparison of adherence and urine growth rate properties of Staphylococcus saprophyticus and Staphylococcus epidermidis.

Authors:  R J Almeida; J H Jorgensen
Journal:  Eur J Clin Microbiol       Date:  1984-12       Impact factor: 3.267

4.  Role of bacterial growth rates in the epidemiology and pathogenesis of urinary infections in women.

Authors:  J D Anderson; F Eftekhar; M Y Aird; J Hammond
Journal:  J Clin Microbiol       Date:  1979-12       Impact factor: 5.948

5.  Urinary tract infection in young women, with special reference to Staphylococcus saprophyticus.

Authors:  W A Gillespie; M A Sellin; P Gill; M Stephens; L A Tuckwell; A L Hilton
Journal:  J Clin Pathol       Date:  1978-04       Impact factor: 3.411

6.  Urinary tract infections due to Staphylococcus saprophyticus biotype 3.

Authors:  J D Anderson; A M Clarke; M E Anderson; J L Isaac-Renton; M G McLoughlin
Journal:  Can Med Assoc J       Date:  1981-02-15       Impact factor: 8.262

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.